Does Rallies show 13F holders for CLBT?

Yes. Rallies tracks hedge fund and 13F ownership data for CLBT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CLBT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLBT. It does not provide personalized investment advice.

CLBT (Cellebrite DI Ltd. Class A Ordinary Shares) Stock Analysis - Hedge Fund Holdings

Cellebrite DI Ltd. Class A Ordinary Shares (CLBT) is a publicly traded Technology sector company. As of May 21, 2026, CLBT trades at $13.35 with a market cap of $3.40B and a P/E ratio of 0.00. CLBT moved -0.45% today. Year to date, CLBT is -25.80%; over the trailing twelve months it is -21.41%. Its 52-week range spans $11.02 to $26.30. Analyst consensus is strong buy with an average price target of $19.67. Rallies surfaces CLBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CLBT stock?

Hedge funds tracked by Rallies that own CLBT include Centerbook Partners, Chilton Investment, Polen Capital, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cellebrite DI Ltd. Class A Ordinary Shares.

CLBT Key Metrics

Key financial metrics for CLBT
Metric	Value
Price	$13.35
Market Cap	$3.40B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$26.30
52-Week Low	$11.02
Volume	319
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding CLBT

Centerbook Partners holds 178.51K shares of CLBT, changed +1201.06% as of Mar 31, 2026.
Chilton Investment holds 41.65K shares of CLBT, changed -7.42% as of Dec 31, 2024.
Polen Capital holds 14.85K shares of CLBT, changed +47.09% as of Mar 31, 2025.
Mangrove Partners holds 12.75K shares of CLBT, changed +0.00% as of Dec 31, 2025.

Latest CLBT News

Cellebrite Reports 19% Revenue Growth and 21% ARR Rise While Price Target Hits $15 — May 15, 2026
Cellebrite Q1 EPS Tops by $0.06, 19% Revenue Growth Triggers 4% Slide — May 14, 2026
Cellebrite Q1 Revenue Rises 19% to $128.3M with ARR up 21% — May 14, 2026
Cellebrite Government Cloud Achieves FedRAMP High Authorization with DOJ Sponsorship — May 6, 2026
Cellebrite Honors 20 JUSTYS Winners, Employees Contribute $67,500 for Fallen Officers — Apr 15, 2026

Recent CLBT Insider Trades

Jewell Marcus sold 12.66K (~$161.66K) on May 18, 2026.
GEE DAVID NICHOLAS sold 228 (~$2.97K) on May 12, 2026.
Jewell Marcus sold 383 (~$4.98K) on May 12, 2026.

CLBT Analyst Consensus

5 analysts cover CLBT: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.67.

Common questions about CLBT

Who owns CLBT stock?: Hedge funds tracked by Rallies that own CLBT include Centerbook Partners, Chilton Investment, Polen Capital, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cellebrite DI Ltd. Class A Ordinary Shares.
Does Rallies show 13F holders for CLBT?: Yes. Rallies tracks hedge fund and 13F ownership data for CLBT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CLBT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLBT. It does not provide personalized investment advice.